Invion Ltd logo

Invion Ltd

ASX:IVX (Australia)  
A$ 0.01 (0%) Apr 12
N/A
P/B:
1.83
Market Cap:
A$ 35.34M ($ 22.93M)
Enterprise V:
A$ 33.39M ($ 21.67M)
Volume:
265.68K
Avg Vol (2M):
1.37M
Also Trade In:
Volume:
265.68K
Avg Vol (2M):
1.37M

Business Description

Description
Invion Ltd is an Australian clinical-stage pharmaceutical drug development company. It is engaged in the development of PhotoDynamic Therapy (PDT) for cancer treatments. The company produces topical and intravenous products suitable for use in skin cancer and solid tumors, such as ovarian, prostate, and lung cancer.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.97
Interest Coverage No Debt
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 23.23
Distress
Grey
Safe
Beneish M-Score 5.41
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Book Growth Rate 44.2

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 63.23
9-Day RSI 55.76
14-Day RSI 53.7
12-1 Month Momentum % -33.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.2
Quick Ratio 9.2
Cash Ratio 3.91
Days Sales Outstanding 121.78

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.3

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -35.79
Net Margin % -34.15
FCF Margin % -138.89
ROE % -8.13
ROA % -7.87
ROIC % -11.33
ROC (Joel Greenblatt) % -141.95
ROCE % -8.52

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio N/A
N/A
N/A
PE Ratio without NRI N/A
N/A
N/A
PS Ratio 5.5
PB Ratio 1.83
EV-to-EBIT -21.27
EV-to-EBITDA -41.18
EV-to-Revenue 7.61
EV-to-FCF -5.48
Earnings Yield (Greenblatt) % -4.7
FCF Yield % -17.24

Financials

ASX:IVX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Invion Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 4.387
EPS (TTM) (A$) 0
Beta 0.45
Volatility % 81.38
14-Day RSI 53.7
14-Day ATR (A$) 0.000434
20-Day SMA (A$) 0.005325
12-1 Month Momentum % -33.33
52-Week Range (A$) 0.004 - 0.008
Shares Outstanding (Mil) 6,424.53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Invion Ltd Filings

Filing Date Document Date Form
No Filing Data

Invion Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Invion Ltd Frequently Asked Questions

What is Invion Ltd(ASX:IVX)'s stock price today?
The current price of ASX:IVX is A$0.01. The 52 week high of ASX:IVX is A$0.01 and 52 week low is A$0.00.
When is next earnings date of Invion Ltd(ASX:IVX)?
The next earnings date of Invion Ltd(ASX:IVX) is .
Does Invion Ltd(ASX:IVX) pay dividends? If so, how much?
Invion Ltd(ASX:IVX) does not pay dividend.

Press Release

Subject Date
No Press Release